Naheed Kurji, Chief Executive Officer

Naheed Kurji is the Co-Founder, President and CEO of Cyclica. Naheed is passionate about building AI-augmented technologies that enable researchers to make more strategic and informed decisions in Healthcare and the life sciences. He spends the majority of his time obsessing over Cyclica’s culture, defining its strategy to best effect change in the pharma industry to achieve the company’s vision, and exploring opportunities for continued innovation.

Persevering through uncertainty

Like many venture-backed entrepreneurs and operators, I have been thinking about the relatively...

CONTINUE READING

The Trailblazers of Innovation

I've now made my way through 5 of Walter Isaacson's books, including The Innovators, Steve Jobs,...

CONTINUE READING

Flipping the (Drug Discovery) Problem on its Head with Polypharmacology

For context: medicines have traditionally been designed to target a single protein with high...

CONTINUE READING

Building a neo-biotech: It's all in the (dream) team. Meet them

I’m often asked how I can lead a deep tech biotech company that’s at the intersection of AI,...

CONTINUE READING

Neither AI nor HI are the silver bullet, but combined, they are

Recently, the Reproducibility Project: Cancer Biology published work that suggests that “more than...

CONTINUE READING

Cyclica successfully integrates DeepMind’s AlphaFold 2

AlphaFold 2 has provided structures for a large percentage of the proteome, perfectly complementary...

CONTINUE READING

Full Speed Ahead: What DeepMind’s Newest Revelation means for Scientific/Research Advancement

Last Week, DeepMind announced on their blog that they had made available, in collaboration with...

CONTINUE READING

Drug Repurposing for COVID19: What has been done, and how we're tackling it.

Originally published on LinkedIn: https://bit.ly/3EqDDeN

Over the past few weeks, we’ve strategized...

CONTINUE READING

Can AlphaFold save lives in epidemics?

Recently, Google DeepMind’s AlphaFold again made news, having overwhelmingly won the latest CASP...

CONTINUE READING

Raising Capital? My Dos and Don'ts Having Raised ~$40M.

Originally published on LinkedIn: https://bit.ly/3jLgf3L 

At Cyclica, over the past 7+ years, we’ve...

CONTINUE READING